Bank Analyst Likes Dendreon’s New CEO, Goldman Thinks Focus Media Share Lag Overdone

Dendreon Corp.(NASDAQ:DNDN): Deutsche Bank said Dendreon’s new CEO, John Johnson, has a history of M&A and his fresh perspective might benefit the company’s near-term strategy. The firm notes Johnson successfully sold Imclone to Eli Lilly (NYSE:LLY) and attempted to sell Savient (NASDAQ:SVNT). Shares are Buy rated with a $20 price target.

Auxilium Pharmaceuticals Inc.(NASDAQ:AUXL): Leerink said the IQWiG released its assessment for Auxilium’s/Pfizer’s (NYSE:PFE) Xiaflex for Dupuytren’s contracture and Esai’s Halavan for breast cancer. The firm said both received a “no proven added benefit” assessment and views the decision as concerning for the drugs and believes it reduces visibility into German reimbursement.

KIT digital, Inc.(NASDAQ:KITD): Janney Capital believes KIT Digital’s technology will be used in Sky’s new Internet TV service expected in 2H 2012. The firm said the deal increases KIT’s visibility when combined with other Tier 1 deployments. Additionally, the firm views KIT Digital as an attractive acquisition target. Shares are Buy rated with a $17 price target.

Focus Media Holding Ltd.(NASDAQ:FMCN): Goldman said Focus Media lagging share performance is due to concerns regarding slowing e-commerce advertising spending, rising costs, and the lingering impact from negative Muddy Waters’ reports. The firm believes the concerns are overdone and that operational trends are robust. Shares are Buy rated with a $43 price target.

Liquidity Services, Inc.(NASDAQ:LQDT): Liquidity Services shares defended at Oppenheimer

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at